Innovations in Chronic Pain Treatment: A Narrative Review on the Role of Cryoablation

Read the full article

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background: Chronic pain is a significant global health issue, with conventional treatment strategies often proving insufficient or causing undesirable side effects. Interventional pain management techniques, including neuromodulation, have gained increasing interest as alternative therapeutic options. Cryoablation, a technique leveraging extreme cold to modulate pain pathways, has emerged as a promising tool in chronic pain management. However, its efficacy and role within current clinical practice remain under evaluation. Methods: A narrative review was conducted by searching PubMed, Scopus, Embase, and Web of Science databases for studies published between 2010 and 2024 using the keywords “Cryoneurolysis,” “Cryoanalgesia,” “Cryoablation,” and “Chronic pain.” Only English‐language studies were included. Studies that examined intraoperative cryoablation or lacked statistical analyses (except case reports) were excluded. Results: A total of 55 studies were included: 4 randomized controlled trials (RCTs), 16 retrospective studies, 4 prospective observational studies, and 31 case reports or small case series. The studies displayed significant heterogeneity in patient selection, targeted nerves, procedural protocols, and follow‐up durations. While two RCTs demonstrated a significant pain reduction compared to control groups, other RCTs reported no significant improvement. Observational studies and case reports frequently reported positive outcomes, with some achieving complete pain relief. Cryoablation appears to be most effective in treating neuropathic pain, particularly in patients with peripheral nerve involvement. Conclusions: Cryoablation is a safe and promising technique for chronic pain management, particularly for selected neuropathic pain conditions. However, the current evidence is limited by study heterogeneity and a lack of high‐quality comparative trials. Further well‐designed randomized studies are necessary to define its long‐term efficacy and its potential role relative to other interventional pain therapies, such as radiofrequency ablation.

Article activity feed